S. Salunke, J. Hempenstall, and R. Kendall, European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.235-244, 2011.
DOI : 10.1016/j.ijpharm.2011.06.040

A. European-medicines, Committee for medicinal products for human use Guideline on pharmaceutical development of medicines for paediatric use, 2012.

T. Sam, T. Ernest, and J. Walsh, A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms ??? An application for paediatric dosage form selection, International Journal of Pharmaceutics, vol.435, issue.2, pp.115-138, 2012.
DOI : 10.1016/j.ijpharm.2012.05.024

V. Klingmann, N. Spomer, and C. Lerch, Favorable Acceptance of Mini-Tablets Compared with Syrup: A??Randomized Controlled Trial in Infants and Preschool Children, The Journal of Pediatrics, vol.163, issue.6, pp.1728-1760, 2013.
DOI : 10.1016/j.jpeds.2013.07.014

D. Van-riet-nales, D. Neef, B. Schobben, and A. , Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, pp.725-756, 2013.
DOI : 10.1023/A:1012050931018

S. Thomson, C. Tuleu, and I. Wong, Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.235-243, 2009.
DOI : 10.1542/peds.2008-2059

A. Zajicek, M. Fossler, and J. Barrett, A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms, The AAPS Journal, vol.15, issue.4, pp.1072-81, 2013.
DOI : 10.1208/s12248-013-9511-5

I. Stoltenberg, G. Winzenburg, and J. Breitkreutz, Solid oral dosage forms for children ? formulations, excipients and acceptance issues, Eur Industrial Pharm, vol.8, pp.4-7, 2011.

J. Standing and C. Tuleu, Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005.
DOI : 10.1016/j.ijpharm.2005.05.006

A. Cram, J. Breitkreutz, and S. Desset-brethes, Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3, 2009.
DOI : 10.1016/j.ijpharm.2008.09.015

S. Winnick, D. Lucas, and A. Hartman, How Do You Improve Compliance?, PEDIATRICS, vol.115, issue.6, pp.718-742, 2005.
DOI : 10.1542/peds.2004-1133

N. Shehab, C. Lewis, and D. Streetman, Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates, Pediatric Critical Care Medicine, vol.10, issue.2, pp.256-265, 2009.
DOI : 10.1097/PCC.0b013e31819a383c

G. Zuccotti and V. Fabiano, Safety issues with ethanol as an excipient in drugs intended for pediatric use, Expert Opinion on Drug Safety, vol.66, issue.4, pp.499-502, 2011.
DOI : 10.1097/SMJ.0b013e31819ba212

H. Levesque, N. Moore, and H. Courtois, Reporting adverse drug reactions by proprietary name, The Lancet, vol.338, issue.8763, p.393, 1991.
DOI : 10.1016/0140-6736(91)90537-Y

M. Turner, J. Duncan, and U. Shah, European Study of Neonatal Exposure to Excipients: An update, International Journal of Pharmaceutics, vol.457, issue.1, pp.357-365, 2013.
DOI : 10.1016/j.ijpharm.2013.08.078

S. Salunke, G. Giacoia, and C. Tuleu, The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1???A need assessment study, International Journal of Pharmaceutics, vol.435, issue.2, pp.101-112, 2012.
DOI : 10.1016/j.ijpharm.2012.05.004

S. Salunke, B. Brandys, and G. Giacoia, The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 ??? The pilot version, International Journal of Pharmaceutics, vol.457, issue.1, pp.310-332, 2013.
DOI : 10.1016/j.ijpharm.2013.09.013

R. Kaushal, D. Goldmann, and C. Keohane, Adverse Drug Events in Pediatric Outpatients, Ambulatory Pediatrics, vol.7, issue.5, pp.383-392, 2007.
DOI : 10.1016/j.ambp.2007.05.005

T. French-drug-agency-schillie, S. Shehab, N. Thomas, and K. , Management of medication errors associated with the use of delivery devices for orally ingested liquid drugs Medication overdoses leading to emergency department visits among children, Am J Prev Med, vol.201337, pp.181-188, 2009.

S. Bailey, A. Pandit, and S. Yin, Predictors of misunderstanding pediatric liquid medication instructions, Fam Med, vol.41, pp.715-736, 2009.

H. Yin, A. Mendelsohn, and M. Wolf, Parents' Medication Administration Errors, Archives of Pediatrics & Adolescent Medicine, vol.164, issue.2, pp.181-187, 2010.
DOI : 10.1001/archpediatrics.2009.269

URL : http://archpedi.jamanetwork.com/data/journals/peds/5184/poa90082_181_186.pdf

E. Ansah, J. Gyapong, and I. Agyepong, Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup, Tropical Medicine and International Health, vol.29, issue.7, pp.496-504, 2001.
DOI : 10.1016/S0160-3450(15)31856-0

A. Isenalumhe and O. Oviawe, Polypharmacy: Its Cost Burden and Barrier to Medical Care in a Drug-Oriented Health Care System, International Journal of Health Services, vol.41, issue.2
DOI : 10.1126/science.176.4034.488

D. Matsui, G. Joubert, and S. Dykxhoorn, Compliance With Prescription Filling in the Pediatric Emergency Department, Archives of Pediatrics & Adolescent Medicine, vol.154, issue.2, pp.195-203, 2000.
DOI : 10.1001/archpedi.154.2.195

L. Wright, J. Woodcock, and R. Scott, Conditioning children when refusal of oral medication is life threatening, Pediatrics, vol.44, pp.969-72, 1969.

A. Lajoinie, E. Henin, and B. Kassai, Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014.
DOI : 10.1016/0005-7916(80)90051-8

T. Michele, B. Knorr, and E. Vadas, Safety of Chewable Tablets for Children, Journal of Asthma, vol.51, issue.5, pp.391-403, 2002.
DOI : 10.1007/BF02722324

V. Yeung and I. Wong, When Do Children Convert from Liquid Antiretroviral to Solid Formulations?, Pharmacy World & Science, vol.12, issue.10, pp.399-402, 2005.
DOI : 10.2165/00128072-200204060-00002

R. Blount, L. Dahlquist, and R. Baer, A brief, effective method for teaching children to swallow pills, Behavior Therapy, vol.15, issue.4, pp.381-388, 1984.
DOI : 10.1016/S0005-7894(84)80006-4

D. Czyzewski, R. Runyan, and M. Lopez, Teaching and maintaining pill-swallowing in HIV-infected children, AIDS Read, vol.10, pp.88-95, 2000.

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

A. European-medicines, Committee for medicinal products for human use Guideline on pharmaceutical development of medicines for paediatric use, 2011.

J. Fontan, F. Mille, and F. Brion, L'administration des m??dicaments ?? l'enfant hospitalis??, Archives de P??diatrie, vol.11, issue.10, pp.1173-84, 2004.
DOI : 10.1016/j.arcped.2004.06.024

B. Best, E. Capparelli, and H. Diep, Pharmacokinetics of Lopinavir/Ritonavir Crushed Versus Whole Tablets in Children, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.58, issue.4, pp.385-91, 2011.
DOI : 10.1097/QAI.0b013e318232b057

R. Richey, U. Shah, and M. Peak, Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatrics, vol.14, issue.1, p.81, 2013.
DOI : 10.1208/s12249-010-9515-8

F. Rocchi and P. Tomasi, The development of medicines for children, Pharmacological Research, vol.64, issue.3, pp.169-75, 2011.
DOI : 10.1016/j.phrs.2011.01.016

D. Matsui, DRUG COMPLIANCE IN PEDIATRICS, Pediatric Clinics of North America, vol.44, issue.1, pp.1-14, 1997.
DOI : 10.1016/S0031-3955(05)70459-4

P. Beardon, M. Mcgilchrist, and A. Mckendrick, Primary non-compliance with prescribed medication in primary care., BMJ, vol.307, issue.6908, pp.846-854, 1993.
DOI : 10.1136/bmj.307.6908.846

H. Chappuy, G. Patteau, and J. Treluyer, Posologie des m??dicaments et observance, Archives de P??diatrie, vol.16, issue.6, pp.968-977, 2009.
DOI : 10.1016/S0929-693X(09)74221-6

E. Sanz, Concordance and children's use of medicines, BMJ, vol.327, issue.7419, pp.858-60, 2003.
DOI : 10.1136/bmj.327.7419.858

A. Lajoinie, Choisir la forme pharmaceutique orale la plus adapt??e ?? l???enfant, Archives de P??diatrie, vol.22, issue.8, pp.877-885, 2015.
DOI : 10.1016/j.arcped.2015.05.012

J. Cloyd, R. Kriel, and C. Jones-saete, Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference, The Journal of Pediatrics, vol.120, issue.4, pp.634-642, 1992.
DOI : 10.1016/S0022-3476(05)82496-5

B. Mccrindle, O. Neill, M. Cullen-dean, and G. , Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial, The Journal of Pediatrics, vol.130, issue.2, pp.266-73, 1997.
DOI : 10.1016/S0022-3476(97)70353-6

E. Ellerbeck, N. Khallaf, E. Ansary, and K. , Caretaker Compliance with Different Antibiotic Formulations for Treatment of Childhood Pneumonia, Journal of Tropical Pediatrics, vol.41, issue.2, pp.103-111, 1995.
DOI : 10.1093/tropej/41.2.103

M. Goode, A. Mcmaugh, and J. Crisp, Adherence issues in children and adolescents receiving highly active antiretroviral therapy, AIDS Care, vol.133, issue.3, pp.403-411, 2003.
DOI : 10.1080/09540129947613

A. European-medicines, Committee for Medicinal Products for Human Use (2013) Guideline on pharmaceutical development of medicines for paediatric use, 2012.

A. European-medicines, Human Medicines Development and Evaluation (2013) Examples of key binding elements in the PIP decisions, 2013.

A. European-medicines, Committee for Proprietary Medicinal Products Guideline on Pharmaceutical Development of Medicines for Paediatric Use, 2012.

J. E. Fontan, F. Mille, F. Brion, F. Aubin, F. Ballereau et al., L'administration des m??dicaments ?? l'enfant hospitalis??, Archives de P??diatrie, vol.11, issue.10, pp.1173-1184, 2004.
DOI : 10.1016/j.arcped.2004.06.024

V. Klingmann, N. Spomer, C. Lerch, I. Stoltenberg, C. Fromke et al., Favorable Acceptance of Mini-Tablets Compared with Syrup: A??Randomized Controlled Trial in Infants and Preschool Children, The Journal of Pediatrics, vol.163, issue.6, pp.1728-1732, 1721.
DOI : 10.1016/j.jpeds.2013.07.014

V. Klingmann, A. Seitz, T. Meissner, J. Breitkreutz, A. Möltner et al., Acceptability of Uncoated Mini-Tablets in Neonates???A Randomized Controlled Trial, The Journal of Pediatrics, vol.167, issue.4, pp.893-896, 2015.
DOI : 10.1016/j.jpeds.2015.07.010

A. Lajoinie, E. Henin, B. Kassai, and D. Terry, Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014.
DOI : 10.1016/0005-7916(80)90051-8

A. Lajoinie, F. V. Valla, and B. Kassai, Risk of medication error administering ciprofloxacin oral suspension in children, Eur. J. Clin. Pharmacol, issue.6, pp.71-769, 2015.

A. Lajoinie, E. Henin, K. A. Nguyen, S. Malik, Y. Mimouni et al., Oral drug dosage forms administered to hospitalized children: Analysis of 117,665 oral administrations in a French paediatric hospital over a 1-year period., International Journal of Pharmaceutics, vol.500, issue.1-2, pp.1-2, 2016.
DOI : 10.1016/j.ijpharm.2016.01.048

Y. J. Manrique, D. J. Lee, F. Islam, L. M. Nissen, J. A. Cichero et al., Crushed Tablets: Does the Administration of Food Vehicles and Thickened Fluids to Aid Medication Swallowing Alter Drug Release?, Journal of Pharmacy & Pharmaceutical Sciences, vol.17, issue.2, pp.207-219, 2014.
DOI : 10.18433/J39W3V

T. M. Michele, B. Knorr, E. B. Vadas, and T. F. Reiss, Safety of Chewable Tablets for Children, Journal of Asthma, vol.51, issue.5, pp.391-403, 2002.
DOI : 10.1007/BF02722324

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-676, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

R. H. Richey, U. U. Shah, M. Peak, J. V. Craig, J. L. Ford et al., Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatrics, vol.14, issue.1, 2013.
DOI : 10.1208/s12249-010-9515-8

S. Salunke, J. Hempenstall, R. Kendall, B. Roger, C. Mroz et al., European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.1-2, 2011.
DOI : 10.1016/j.ijpharm.2011.06.040

S. Salunke, G. Giacoia, and C. Tuleu, The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1???A need assessment study, International Journal of Pharmaceutics, vol.435, issue.2, pp.101-111, 2012.
DOI : 10.1016/j.ijpharm.2012.05.004

S. Salunke, B. Brandys, G. Giacoia, and C. Tuleu, The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 ??? The pilot version, International Journal of Pharmaceutics, vol.457, issue.1, pp.310-322, 2013.
DOI : 10.1016/j.ijpharm.2013.09.013

N. Spomer, V. Klingmann, I. Stoltenberg, C. Lerch, T. Meissner et al., Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study, Archives of Disease in Childhood, vol.97, issue.3, pp.283-286, 2012.
DOI : 10.1136/archdischild-2011-300958

J. F. Standing and C. Tuleu, Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005.
DOI : 10.1016/j.ijpharm.2005.05.006

D. A. Van-riet-nales, B. J. De-neef, A. F. Schobben, J. A. Ferreira, T. C. Egberts et al., Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, pp.98-725, 2013.
DOI : 10.1023/A:1012050931018

D. A. Van-riet-nales, M. E. Doeve, A. E. Nicia, S. Teerenstra, K. Notenboom et al., The accuracy, precision and sustainability of different techniques for tablet subdivision: Breaking by hand and the use of tablet splitters or a kitchen knife, International Journal of Pharmaceutics, vol.466, issue.1-2, pp.1-2, 2014.
DOI : 10.1016/j.ijpharm.2014.02.031

R. Venables, H. Batchelor, J. Hodson, H. Stirling, and J. Marriott, Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.1-2, 2015.
DOI : 10.1016/j.ijpharm.2015.01.023

A. L. Wright, D. A. Stern, F. Kauffmann, and F. D. Martinez, Factors influencing gender differences in the diagnosis and treatment of asthma in childhood: The Tucson Children's Respiratory Study, Pediatric Pulmonology, vol.172, issue.4, p.41, 2006.
DOI : 10.1164/ajrccm.158.2.9705079

C. Inserm-u1028, H. , C. , A. , N. Bossardneonatology et al., CNRS Xavier Dode (Pharmacy Department, HCL) and the CNIHM (Drug Information National Hospital Centre, Thériaque 1 ) Alain Lachaux (Paediatric Hepatogastro-Enterology, Odile Boespflug-Tanguy (Paediatric Neurology and Metabolic DiseasesPaediatric Nephrology/Rheumatology, IBCP-UMR 5305CNRS, HCL/UCBL- Lyon1), Georges Deschênes (Paediatric Nephrology, CNRS- UMR7134, APHP), Vincent Des Portes (Paediatric Neurology HCL) Emilie Henin (CNRS UMR5558, UCBL-Lyon1), Evelyne Jacqz-Aigrain (Paediatric Pharmacology and Pharmacogenetics, Clinical Centre of Investigation, Inserm-U1426, APHP), Etienne Javouhey (Paediatric Intensive Care Unit Behrouz Kassai (Clinical Centre of Investigation, HCL) Salma Malik (Clinical Centre of Investigation, HCL), Catherine Michel (Computer and Information System Management, HCL), Yanis Minouni (Clinical Centre of Investigation, HCL) Marc Nicolino (Paediatric Endocrinology and Metabolic Diseases Nathalie Paret Benjamin Riche (CNRS UMR5558, HCL/UCBL-Lyon1), Aurélie Portefaix (Clinical Centre of Investigation, HCL), Corinne Pulce (Toxicovigilance and Poison Control Centre, HCL), Jean-Marc Sapori (Toxicovigilance and Poison Control Centre, HCL) Thierry Vial

S. A. Shammari, T. Khoja, and M. J. Yamani, Compliance with short-term antibiotic therapy among patients attending primary health centres in Riyadh, Saudi Arabia, Journal of the Royal Society of Health, vol.43, issue.857, pp.231-234, 1995.
DOI : 10.1136/bmj.2.5857.18

E. K. Ansah, J. O. Gyapong, I. A. Agyepong, and D. B. Evans, Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup, Tropical Medicine and International Health, vol.29, issue.7, pp.496-504, 2001.
DOI : 10.1016/S0160-3450(15)31856-0

S. C. Bailey, A. U. Pandit, S. Yin, A. Federman, T. C. Davis et al., Predictors of misunderstanding pediatric liquid medication instructions, Fam. Med, issue.10, pp.41-715, 2009.

H. Batchelor, S. Salunke, and C. Tuleu, European Paediatric Formulation Initiative (EuPFI), 2015. Formulating better medicines for children-reflections, Int. J. Pharm, pp.1-2

H. K. Batchelor and J. F. Marriott, Formulations for children: problems and solutions, British Journal of Clinical Pharmacology, vol.97, issue.S2, pp.405-418, 2015.
DOI : 10.1136/archdischild-2011-300909

URL : http://onlinelibrary.wiley.com/doi/10.1111/bcp.12268/pdf

H. Bauchner, L. Simpson, and J. Chessare, Changing physician behaviour, Archives of Disease in Childhood, vol.84, issue.6, pp.459-462, 2001.
DOI : 10.1136/adc.84.6.459

A. Buusman, M. Andersen, C. Merrild, and B. Elverdam, Factors influencing GPs??? choice between drugs in a therapeutic drug group. A qualitative study, Scandinavian Journal of Primary Health Care, vol.32, issue.4, pp.208-213, 2007.
DOI : 10.1093/019881092X.001.0001

A. Cram, J. Breitkreutz, S. Desset-brethes, T. Nunn, and C. Tuleu, Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3
DOI : 10.1016/j.ijpharm.2008.09.015

A. S. Dajani, Adherence to physicians' instructions as a factor in managing streptococcal pharyngitis, Pediatrics, vol.97, issue.6, pp.976-980, 1996.

J. E. Fontan, F. Mille, F. Brion, F. Aubin, F. Ballereau et al., Drug administration to paediatric inpatient, Arch. Pediatr, issue.10, pp.11-1173, 2004.

A. Lajoinie, E. Henin, B. Kassai, and D. Terry, Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014.
DOI : 10.1016/0005-7916(80)90051-8

A. Lajoinie, F. V. Valla, and B. Kassai, Risk of medication error administering ciprofloxacin oral suspension in children, Eur. J. Clin. Pharmacol, issue.6, pp.71-769, 2015.

M. D. Larsen, T. Cars, and J. Hallas, A MiniReview of the Use of Hospital-based Databases in Observational Inpatient Studies of Drugs, Basic & Clinical Pharmacology & Toxicology, vol.25, issue.1, pp.13-18, 2013.
DOI : 10.1177/1062860609359934

R. Mangione-smith, E. A. Mcglynn, M. N. Elliott, P. Krogstad, and R. H. Brook, The Relationship Between Perceived Parental Expectations and Pediatrician Antimicrobial Prescribing Behavior, Pediatrics, vol.103, issue.4, pp.711-718, 1999.
DOI : 10.1542/peds.103.4.711

D. M. Matsui, Drug compliance in pediatrics. Clinical and research issues, Pediatr. Clin. N. Am, vol.4, issue.1, pp.1-14, 1997.

M. E. Mattar, J. Markello, and S. J. Yaffe, Inadequacies in the pharmacologic management of ambulatory children, The Journal of Pediatrics, vol.87, issue.1, pp.137-141, 1975.
DOI : 10.1016/S0022-3476(75)80090-4

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-676, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

S. Ranmal and C. Tuleu, Demonstrating Evidence of Acceptability: The ???Catch-22??? of Pediatric Formulation Development, Clinical Pharmacology & Therapeutics, vol.32, issue.5, pp.582-584, 2013.
DOI : 10.1016/j.clinthera.2010.05.005

R. H. Richey, U. U. Shah, M. Peak, J. V. Craig, J. L. Ford et al., Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatrics, vol.14, issue.1, p.81, 2013.
DOI : 10.1208/s12249-010-9515-8

S. Salunke, J. Hempenstall, R. Kendall, B. Roger, C. Mroz et al., European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.1-2, 2011.
DOI : 10.1016/j.ijpharm.2011.06.040

G. T. Schumock, S. M. Walton, H. Y. Park, E. A. Nutescu, J. C. Blackburn et al., Factors that Influence Prescribing Decisions, Annals of Pharmacotherapy, vol.149, issue.4, pp.557-562, 2004.
DOI : 10.1001/archinte.163.18.2213

M. Slavkova and J. Breitkreutz, Orodispersible drug formulations for children and elderly, European Journal of Pharmaceutical Sciences, vol.75, pp.2-9, 2015.
DOI : 10.1016/j.ejps.2015.02.015

N. Spomer, V. Klingmann, I. Stoltenberg, C. Lerch, T. Meissner et al., Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study, Archives of Disease in Childhood, vol.97, issue.3, pp.283-286, 2012.
DOI : 10.1136/archdischild-2011-300958

J. F. Standing and C. Tuleu, Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005.
DOI : 10.1016/j.ijpharm.2005.05.006

K. Sunakawa, H. Akita, S. Iwata, Y. Sato, and R. Fujii, Rationale Antibiotikatherapie bei p??diatrischen Infektionen, Infection, vol.60, issue.S2, pp.74-78, 1995.
DOI : 10.11150/kansenshogakuzasshi1970.60.549

M. Theodorou, V. Tsiantou, A. Pavlakis, N. Maniadakis, V. Fragoulakis et al., Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey, BMC Health Services Research, vol.31, issue.1, p.150, 2009.
DOI : 10.1111/j.1365-2710.2006.00776.x

S. A. Thomson, C. Tuleu, I. C. Wong, S. Keady, K. G. Pitt et al., Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.235-238, 2009.
DOI : 10.1542/peds.2008-2059

D. A. Van-riet-nales, B. J. De-neef, A. F. Schobben, J. A. Ferreira, T. C. Egberts et al., Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, pp.98-725, 2013.
DOI : 10.1023/A:1012050931018

D. A. Van-riet-nales, J. A. Ferreira, A. F. Schobben, B. J. De-neef, T. C. Egberts et al., Methods of administering oral formulations and child acceptability, International Journal of Pharmaceutics, vol.491, issue.1-2, pp.1-2, 2015.
DOI : 10.1016/j.ijpharm.2015.06.047

R. Venables, H. Batchelor, J. Hodson, H. Stirling, and J. Marriott, Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.1-2, 2015.
DOI : 10.1016/j.ijpharm.2015.01.023

R. Venables, H. Stirling, H. Batchelor, and J. Marriott, Problems with oral formulations prescribed to children: a focus group study of healthcare professionals, International Journal of Clinical Pharmacy, vol.6, issue.3, pp.1057-1067, 2015.
DOI : 10.18433/J38887

J. Walsh and S. Mills, Conference Report: Formulating Better Medicines for Children: 4th European Paediatric Formulation Initiative Conference, Therapeutic Delivery, vol.4, issue.1, pp.21-25, 2013.
DOI : 10.1016/j.ijpharm.2012.05.070

H. S. Yin, A. L. Mendelsohn, M. S. Wolf, R. M. Parker, A. Fierman et al., Parents' Medication Administration Errors, Archives of Pediatrics & Adolescent Medicine, vol.164, issue.2, pp.181-186, 2010.
DOI : 10.1001/archpediatrics.2009.269

R. 1. Guet, A. Moutard, and M. L. , New treatments of epilepsy in infancy] Archives de pediatrie, p.272

A. Lajoinie, E. Henin, and B. Kassai, Oral formulation of choice for children] Archives de 276 pediatrie : organe officiel de la Societe francaise de pediatrie, pp.877-85, 2015.

S. Salunke, J. Hempenstall, and R. Kendall, European Paediatric Formulation Initiative's 278 (EuPFI) 2nd conference commentary--Formulating better medicines for children. International journal 279 of pharmaceutics, pp.235-244, 2011.

M. C. Nahata, Lack of pediatric drug formulations, Pediatrics, vol.104, pp.607-616, 1999.

E. Schirm, H. Tobi, T. W. De-vries, I. Choonara, D. Jong-van-den-berg et al., Lack of appropriate formulations of medicines for children in the community, Acta Paediatrica, vol.104, issue.3, pp.1486-1495, 2003.
DOI : 10.1111/j.1651-2227.2003.tb00837.x

D. M. Matsui, Drug compliance in pediatrics. Clinical and research issues. Pediatric clinics of 285

A. S. Dajani, Adherence to physicians' instructions as a factor in managing streptococcal 287 pharyngitis, Pediatrics, vol.97, pp.976-80, 1996.

A. C. Modi, J. R. Rausch, and T. A. Glauser, Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy, JAMA, vol.305, issue.16, pp.1669-76, 2011.
DOI : 10.1001/jama.2011.506

L. Bigeard, The role of medication and sugars in pediatric dental patients, p.291

S. Pawar and A. Kumar, Issues in the Formulation of Drugs for Oral Use in Children, Pediatric Drugs, vol.7, issue.3, pp.371-380, 2002.
DOI : 10.2165/00128072-200204060-00004

M. E. Mattar, J. Markello, and S. J. Yaffe, Inadequacies in the pharmacologic management of 295 ambulatory children. The Journal of pediatrics, pp.137-178, 1975.

A. Lajoinie, F. V. Valla, B. Kassai, and E. Group, Risk of medication error administering ciprofloxacin oral suspension in children, European Journal of Clinical Pharmacology, vol.71, issue.6, pp.769-70, 2015.
DOI : 10.1007/s00228-015-1842-y

T. Nunn and J. Williams, Formulation of medicines for children British journal of clinical 299 pharmacology, pp.674-680, 2005.

E. K. Ansah, J. O. Gyapong, I. A. Agyepong, and D. B. Evans, Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup, Tropical Medicine and International Health, vol.29, issue.7, pp.496-504, 2001.
DOI : 10.1016/S0160-3450(15)31856-0

V. W. Yeung and I. C. Wong, When do children convert from liquid antiretroviral to solid 304 formulations? Pharm World Sci, pp.399-402, 2005.

P. A. Garvie, S. Lensing, and S. N. Rai, Efficacy of a pill-swallowing training intervention to 306

N. Spomer, V. Klingmann, and I. Stoltenberg, Acceptance of uncoated mini-tablets in young 309 children: results from a prospective exploratory cross-over study. Archives of disease in childhood, pp.310-283, 2012.

S. A. Thomson, C. Tuleu, and I. C. Wong, Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.235-243, 2009.
DOI : 10.1542/peds.2008-2059

D. A. Van-riet-nales, D. Neef, B. J. Schobben, and A. F. , Acceptability of different oral 314 formulations in infants and preschool children, Archives of disease in childhood, pp.315-336, 2013.

D. I. Czyzewski, R. D. Runyan, M. A. Lopez, and N. R. Calles, Teaching and maintaining pill- 316 swallowing in HIV-infected children, AIDS Reader, vol.10, issue.317, pp.88-95, 2000.

E. Perucca, Pharmacological and Therapeutic Properties of Valproate, CNS Drugs, vol.20, issue.1, pp.695-714, 2002.
DOI : 10.3171/jns.1997.87.2.0252

J. C. Cloyd, R. L. Kriel, and C. M. Jones-saete, Comparison of sprinkle versus syrup 325 formulations of valproate for bioavailability, tolerance, and preference. The Journal of pediatrics, pp.634-642, 1992.

J. Motte, J. M. Pedespan, M. Sevestre, C. Chiron, and A. M. Groupe, Acceptability and tolerance 328 of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic 329 children from 3 years old] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie Committee for Medicinal Products for Human Use. Reflection 332 paper: formulations of choice for the paediatric population, pp.1533-1542, 2005.

E. Qwp, European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline 340 on pharmaceutical development of medicines for paediatric use, 2011.

A. Patel, L. Jacobsen, R. Jhaveri, and K. K. Bradford, Effectiveness of Pediatric Pill Swallowing Interventions: A Systematic Review, PEDIATRICS, vol.135, issue.5, pp.883-892, 2015.
DOI : 10.1542/peds.2014-2114

E. O. Meltzer, M. J. Welch, and N. K. Ostrom, Pill Swallowing Ability and Training in Children 6 to 11 Years of Age, Clinical Pediatrics, vol.94, issue.7, pp.725-758, 2006.
DOI : 10.1016/S0140-6736(97)07302-9

G. A. Walco, A behavioral treatment for difficulty in swallowing pills Journal of behavior 347 therapy and experimental psychiatry, pp.127-135, 1986.

R. L. Blount, L. M. Dahlquist, R. A. Baer, and D. Wuori, A brief, effective method for teaching children to swallow pills, Behavior Therapy, vol.15, issue.4, pp.381-388, 1984.
DOI : 10.1016/S0005-7894(84)80006-4

R. S. Fisher, J. H. Cross, and J. A. French, Operational classification of seizure types by the 351

E. H. Davies and C. Tuleu, Medicines for children: a matter of taste. The Journal of pediatrics, pp.599-604, 2008.

B. Vrijens and E. Goetghebeur, Comparing compliance patterns between randomized treatments, Controlled Clinical Trials, vol.18, issue.3, p.356
DOI : 10.1016/S0197-2456(96)00235-8

T. M. Michele, B. Knorr, E. B. Vadas, and T. F. Reiss, Safety of Chewable Tablets for Children, Journal of Asthma, vol.51, issue.5, p.358
DOI : 10.1007/BF02722324

J. Ding, Y. Wang, and W. Lin, A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation, Clinical Pharmacokinetics, vol.47, issue.3, pp.305-322, 2015.
DOI : 10.1080/15563650902752376

C. Chiron, Therapeutic follow-up observational study and population kinetics ancillary study 366 of valproate microgranules (Micropakine® SR) in patients aged between 6 months and 15 years 367 suffering from epilepsy, VAPOP Study, 2009.

K. Hall, N. Otten, and B. Johnston, A multivariable analysis of factors governing the steady, p.369

J. C. Cloyd, J. H. Fischer, R. L. Kriel, and D. M. Kraus, Valproic acid pharmacokinetics in children, p.371

E. Desoky, E. Fuseau, D. Amry, S. Cosson, and V. , Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients, European Journal of Clinical Pharmacology, vol.59, issue.11, pp.783-90, 2004.
DOI : 10.1007/s00228-003-0699-7

D. C. Jiang, L. Wang, and Y. Q. Wang, Population pharmacokinetics of valproate in Chinese children with epilepsy, Acta Pharmacologica Sinica, vol.7, issue.10, pp.1677-84, 2007.
DOI : 10.1111/j.1365-2125.2004.02241.x

B. B. Serrano, G. Sanchez, M. J. Otero, and M. J. , Valproate population pharmacokinetics in children, Journal of Clinical Pharmacy and Therapeutics, vol.27, issue.1, pp.73-80, 1999.
DOI : 10.1111/j.1365-2125.1989.tb05372.x

J. H. Botha, A. L. Gray, and R. Miller, A Model for Estimating Individualized Valproate Clearance Values in Children, The Journal of Clinical Pharmacology, vol.65, issue.10, pp.1020-1024, 1995.
DOI : 10.1111/j.1600-0404.1982.tb03106.x

S. M. Jankovic, J. R. Milovanovic, and S. Jankovic, Factors influencing valproate pharmacokinetics in children and adults, Int. Journal of Clinical Pharmacology and Therapeutics, vol.48, issue.11, pp.767-75, 2010.
DOI : 10.5414/CPP48767

G. Bano, S. Gupta, K. L. Gupta, and R. K. Raina, Pharmacokinetics of valproic acid after 384 administration of three oral formulations in healthy adults, J Assoc Physicians India, vol.38, pp.629-659, 1990.

C. Bazzoli, S. Retout, and F. Mentre, Design evaluation and optimisation in multiple response 390 nonlinear mixed effect models: PFIM 3.0. Comput Methods Programs Biomed, pp.55-65, 2010.

D. Battino, M. Estienne, and G. Avanzini, Clinical pharmacokinetics of antiepileptic drugs in 392 paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide, p.393

V. Klingmann, N. Spomer, and C. Lerch, Favorable acceptance of mini-tablets compared 395 with syrup: a randomized controlled trial in infants and preschool children. The Journal of pediatrics, pp.1728-1760, 2013.

A. Arzimanoglou, E. Ben-menachem, and J. Cramer, The evolution of antiepileptic drug 398 development and regulation. Epileptic disorders : international epilepsy journal with videotape, pp.3-399, 2010.

E. Beghi, P. Messina, and E. Pupillo, Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsy, Epilepsy Research, vol.100, issue.1-2, pp.142-51, 2012.
DOI : 10.1016/j.eplepsyres.2012.02.005

L. M. Ingerski, E. A. Hente, A. C. Modi, and K. A. Hommel, Electronic measurement of medication 403

A. Lajoinie, E. Henin, B. Kassai, and D. Terry, Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014.
DOI : 10.1016/0005-7916(80)90051-8

F. Liu, S. Ranmal, H. Batchelor, M. Orlu-gul, T. Ernest et al., Patient-Centred Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations, Drugs, vol.370, issue.106, pp.1871-89, 2014.
DOI : 10.1016/j.ijpharm.2008.11.005

P. Kozarewicz, Regulatory perspectives on acceptability testing of dosage forms in children, International Journal of Pharmaceutics, vol.469, issue.2, pp.245-253, 2014.
DOI : 10.1016/j.ijpharm.2014.03.057

J. Standing and C. Tuleu, Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005.
DOI : 10.1016/j.ijpharm.2005.05.006

A. Cram, J. Breitkreutz, S. Desset-brethes, T. Nunn, and C. Tuleu, Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3, 2009.
DOI : 10.1016/j.ijpharm.2008.09.015

S. Salunke, J. Hempenstall, R. Kendall, B. Roger, C. Mroz et al., European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.235-244, 2011.
DOI : 10.1016/j.ijpharm.2011.06.040

A. European-medicines, 10-year Report to the European Commission -General report on the experience acquired as a result of the application of the Paediatric Regulation, 2016.

E. Cruz-arrieta, Pill-swallowing Training : A Brief Pediatric Oncology Report, Anglais, vol.15, issue.7, p.49, 2008.

E. Davies and C. Tuleu, Medicines for Children: A Matter of Taste, The Journal of Pediatrics, vol.153, issue.5, pp.599-604, 2008.
DOI : 10.1016/j.jpeds.2008.06.030

C. Milne and J. Bruss, The economics of pediatric formulation development for off-patent drugs, Clinical Therapeutics, vol.30, issue.11, pp.2133-2178, 2008.
DOI : 10.1016/j.clinthera.2008.11.019

R. Venables, H. Batchelor, J. Hodson, H. Stirling, and J. Marriott, Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.55-62, 2015.
DOI : 10.1016/j.ijpharm.2015.01.023

R. Greenberg, Overview of patient compliance with medication dosing: a literature review, Clin Ther, vol.6, issue.5, pp.592-601, 1984.

S. Salunke, G. Giacoia, and C. Tuleu, The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1???A need assessment study, International Journal of Pharmaceutics, vol.435, issue.2, pp.101-112, 2012.
DOI : 10.1016/j.ijpharm.2012.05.004

S. Salunke, B. Brandys, G. Giacoia, and C. Tuleu, The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 ??? The pilot version, International Journal of Pharmaceutics, vol.457, issue.1, pp.310-332, 2013.
DOI : 10.1016/j.ijpharm.2013.09.013

R. Roberts, W. Rodriguez, D. Murphy, and T. Crescenzi, Pediatric Drug Labeling, JAMA, vol.290, issue.7, pp.905-916, 2003.
DOI : 10.1001/jama.290.7.905

URL : http://jama.jamanetwork.com/data/journals/jama/4892/joc30331.pdf

D. Healy, Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors, Psychotherapy and Psychosomatics, vol.72, issue.2, pp.71-80, 2003.
DOI : 10.1159/000068691

C. Whittington, T. Kendall, P. Fonagy, D. Cottrell, A. Cotgrove et al., Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data, The Lancet, vol.363, issue.9418, pp.1341-1346, 2004.
DOI : 10.1016/S0140-6736(04)16043-1

J. Bridge, S. Iyengar, C. Salary, R. Barbe, B. Birmaher et al., Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric, Bibliographie, vol.172, p.180

T. Johnson, The problems in scaling adult drug doses to children, Archives of Disease in Childhood, vol.93, issue.3, pp.207-218, 2008.
DOI : 10.1136/adc.2006.114835

P. Janiaud, A. Lajoinie, F. Cour-andlauer, C. Cornu, P. Cochat et al., Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children, Journal of Clinical Epidemiology, vol.68, issue.10, pp.1221-1252, 2015.
DOI : 10.1016/j.jclinepi.2015.06.021

L. Ku and P. Smith, Dosing in neonates: special considerations in physiology and trial design, Pediatric Research, vol.14, issue.1-1, pp.1-12, 2015.
DOI : 10.1016/j.jchromb.2010.10.009

A. European-medicines, 5-year Report to the European Commission -General report on the experience acquired as a result of the application of the Paediatric Regulation, 2012.

A. Guet and M. Moutard, [New treatments of epilepsy in infancy] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, pp.1041-1045, 2007.

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

A. European-medicines, Committee for Medicinal Products for Human Use. Guideline on pharmaceutical development of medicines for paediatric use, 2013.

V. Klingmann, N. Spomer, C. Lerch, I. Stoltenberg, C. Fromke et al., Favorable Acceptance of Mini-Tablets Compared with Syrup: A??Randomized Controlled Trial in Infants and Preschool Children, The Journal of Pediatrics, vol.163, issue.6, pp.1728-1760, 2013.
DOI : 10.1016/j.jpeds.2013.07.014

D. Van-riet-nales, D. Neef, B. Schobben, A. Ferreira, J. Egberts et al., Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, 2013.
DOI : 10.1023/A:1012050931018

A. European-medicines, Committee for Medicinal Products for Human Use. Draft: Guideline on pharmaceutical development of medicines for paediatric use, 2011.

B. Mccrindle, O. Neill, M. Cullen-dean, G. Helden, and E. , Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial, The Journal of Pediatrics, vol.130, issue.2, pp.266-73, 1997.
DOI : 10.1016/S0022-3476(97)70353-6

H. Batchelor and J. Marriott, Formulations for children: problems and solutions, British Journal of Clinical Pharmacology, vol.97, issue.S2, pp.405-423, 2015.
DOI : 10.1136/archdischild-2011-300909

URL : http://onlinelibrary.wiley.com/doi/10.1111/bcp.12268/pdf

D. Czyzewski, R. Runyan, M. Lopez, and N. Calles, Teaching and maintaining pillswallowing in HIV-infected children, AIDS Reader, vol.10, issue.2, pp.88-95, 2000.

P. Garvie, S. Lensing, and S. Rai, Efficacy of a Pill-Swallowing Training Intervention to Improve Antiretroviral Medication Adherence in Pediatric Patients With HIV/AIDS, PEDIATRICS, vol.119, issue.4, pp.893-902, 2007.
DOI : 10.1542/peds.2006-1488

R. Blount, L. Dahlquist, R. Baer, and D. Wuori, A brief, effective method for teaching children to swallow pills, Behavior Therapy, vol.15, issue.4, pp.381-388, 1984.
DOI : 10.1016/S0005-7894(84)80006-4

G. Walco, A behavioral treatment for difficulty in swallowing pills, Journal of Behavior Therapy and Experimental Psychiatry, vol.17, issue.2, pp.127-135, 1986.
DOI : 10.1016/0005-7916(86)90050-9

J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated, The Cochrane Collaboration, 2011.

A. Modi, J. Rausch, and T. Glauser, Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy, JAMA, vol.305, issue.16, pp.1669-76, 2011.
DOI : 10.1001/jama.2011.506

E. Faught, M. Duh, J. Weiner, A. Guerin, and M. Cunnington, Nonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study, Neurology, vol.71, issue.20, pp.1572-1580, 2008.
DOI : 10.1212/01.wnl.0000319693.10338.b9

R. Faught, J. Weiner, A. Guerin, M. Cunnington, and M. Duh, Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study, Epilepsia, vol.12, issue.Suppl. 7, pp.501-510, 2009.
DOI : 10.1017/S1092852900008464

A. Arzimanoglou, E. Ben-menachem, J. Cramer, T. Glauser, R. Seeruthun et al., The evolution of antiepileptic drug development and regulation. Epileptic disorders : international epilepsy journal with videotape, pp.3-15, 2010.

E. Perucca, Pharmacological and Therapeutic Properties of Valproate, CNS Drugs, vol.20, issue.1, pp.695-714, 2002.
DOI : 10.3171/jns.1997.87.2.0252

R. Guerrini, Valproate as a Mainstay of Therapy for Pediatric Epilepsy, Pediatric Drugs, vol.33, issue.1-2, pp.113-142, 2006.
DOI : 10.1212/01.WNL.0000123693.82339.FC

J. Motte, J. Pedespan, M. Sevestre, C. Chiron, and A. Groupe, Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, pp.1533-1542, 2005.

R. Venables, H. Batchelor, J. Hodson, H. Stirling, and J. Marriott, Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.1873-3476
DOI : 10.1016/j.ijpharm.2015.01.023

J. Cloyd, R. Kriel, C. Jones-saete, B. Ong, J. Jancik et al., Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference, The Journal of Pediatrics, vol.120, issue.4, pp.634-642, 1992.
DOI : 10.1016/S0022-3476(05)82496-5

H. Neels, A. Sierens, K. Naelaerts, S. Scharpe, G. Hatfield et al., Abstract, Clinical Chemistry and Laboratory Medicine (CCLM), vol.62, issue.11, pp.1228-55, 2004.
DOI : 10.1111/j.1365-2125.1987.tb03247.x

L. Osterberg and T. Blaschke, Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, pp.487-97, 2005.
DOI : 10.1056/NEJMra050100

D. Battino, M. Estienne, and G. Avanzini, Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric Patients, Clinical Pharmacokinetics, vol.29, issue.4, pp.257-86, 1995.
DOI : 10.2165/00003088-199529040-00005

J. Ding, Y. Wang, W. Lin, C. Wang, L. Zhao et al., A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation, Clinical Pharmacokinetics, vol.47, issue.3, pp.305-322, 2015.
DOI : 10.1080/15563650902752376

C. Chiron, Therapeutic follow-up observational study and population kinetics ancillary study of valproate microgranules (Micropakine ® SR) in patients aged between 6 months and 15 years suffering from epilepsy. VAPOP Study, 2009.

K. Hall, N. Otten, B. Johnston, J. Irvine-meek, M. Leroux et al., A Multivariable Analysis of Factors Governing the Steady-State Pharmacokinetics of Valproic Acid in 52 Young Epileptics, The Journal of Clinical Pharmacology, vol.28, issue.4, pp.261-269, 1985.
DOI : 10.1038/clpt.1980.192

E. Desoky, E. Fuseau, D. Amry, S. Cosson, and V. , Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients, European Journal of Clinical Pharmacology, vol.59, issue.11, pp.783-90, 2004.
DOI : 10.1007/s00228-003-0699-7

D. Jiang, L. Wang, Y. Wang, L. Li, W. Lu et al., Population pharmacokinetics of valproate in Chinese children with epilepsy, Acta Pharmacologica Sinica, vol.7, issue.10, pp.1677-84, 2007.
DOI : 10.1111/j.1365-2125.2004.02241.x

J. Botha, A. Gray, and R. Miller, A Model for Estimating Individualized Valproate Clearance Values in Children, The Journal of Clinical Pharmacology, vol.65, issue.10, pp.1020-1024, 1995.
DOI : 10.1111/j.1600-0404.1982.tb03106.x

S. Jankovic, J. Milovanovic, and S. Jankovic, Factors influencing valproate pharmacokinetics in children and adults, Int. Journal of Clinical Pharmacology and Therapeutics, vol.48, issue.11, pp.767-75, 2010.
DOI : 10.5414/CPP48767

D. Food and H. Administration, International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population

R. Reed, J. Meinhold, S. Dutta, W. Liu, and Y. Qiu, What do the suffixes - XR, ER, Chrono, Chronosphere - really mean as it pertains to modified-release antiepileptic drugs?, Journal of Clinical Pharmacy and Therapeutics, vol.38, issue.Suppl. 7, pp.373-83, 2010.
DOI : 10.1212/WNL.38.8.1319

G. Bano, S. Gupta, K. Gupta, and R. Raina, Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults, J Assoc Physicians India, vol.38, issue.9, pp.629-659, 1990.

S. Dutta and R. Reed, Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United States, Epilepsy Research, vol.73, issue.3, pp.275-83, 2007.
DOI : 10.1016/j.eplepsyres.2006.11.005

A. Fujii, N. Yasui-furukori, T. Nakagami, T. Niioka, M. Saito et al., Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations, Drug Des Devel Ther, vol.2, pp.139-183, 2009.

C. Bazzoli, S. Retout, and F. Mentre, Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0, Computer Methods and Programs in Biomedicine, vol.98, issue.1, pp.55-65, 2010.
DOI : 10.1016/j.cmpb.2009.09.012

URL : https://hal.archives-ouvertes.fr/inserm-00431457

A. European-medicines, Reflection paper formulations of choice for the paediatric population, 2005.

G. Moulis, M. Lapeyre-mestre, A. Palmaro, G. Pugnet, J. Montastruc et al., French health insurance databases: What interest for medical research?, La Revue de M??decine Interne, vol.36, issue.6, pp.411-7180, 2015.
DOI : 10.1016/j.revmed.2014.11.009